The LYMErix™ Story: FDA Approval to Market Withdrawal ─ Learning from History

This is a piece on the Lymerix Vaccine controversy, written by Patricia V. Smith, President, Lyme Disease Association, Inc., 

Lyme Times Special Issue Sept. 2018 The LYMErix™ Story: FDA Approval to Market Withdrawal ─ Learning from History

Click here to read article